Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cellsJulen Rodríguez-Castejón(University of the Basque Country), Jan A. A. M. Kamps(University Medical Center Groningen)Journal of Drug Delivery Science and TechnologyJuly 9, 202410.1016/j.jddst.2024.105954Cited by 0SaveCiteExport RISWatch citationsRelated PapersDevelopment of a Combined Lipid-Based Nanoparticle Formulation for Enhanced siRNA Delivery to Vascular Endothelial Cells|Pharmaceutics|2022|22